脳科学辞典

「Test」の版間の差分

ページ

Test (ソースを閲覧)

2013年10月8日 (火) 15:52時点における版

251 バイト追加 、 2013年10月8日 (火)
細
編集の要約なし
細編集の要約なし
細編集の要約なし
50行目: 50行目:
| [[Src]] ||Srcus|| 2005, 2005, 2007 || 3-3 || <ref><pubmed>11752449</pubmed></ref><ref><pubmed> 15846350</pubmed></ref><ref><pubmed> 17284441</pubmed></ref>
| [[Src]] ||Srcus|| 2005, 2005, 2007 || 3-3 || <ref><pubmed>11752449</pubmed></ref><ref><pubmed> 15846350</pubmed></ref><ref><pubmed> 17284441</pubmed></ref>
|-
|-
| Protein kinase C (PKC) ||CKAR, CY-PKCdelta|| 2003, 2005 || 3-3, 3-1 || <ref><pubmed>12782683</pubmed></ref><ref><pubmed> 15611119</pubmed></ref>
| プロテインキナーゼC (PKC) ||CKAR, CY-PKCdelta|| 2003, 2005 || 3-3, 3-1 || <ref><pubmed>12782683</pubmed></ref><ref><pubmed> 15611119</pubmed></ref>
|-
|-
| Protein kinase D (PKD) ||DKAR|| 2007 || 3-3 || <ref><pubmed>17189263</pubmed></ref>
| プロテインキナーゼD (PKD) ||DKAR|| 2007 || 3-3 || <ref><pubmed>17189263</pubmed></ref>
|-
|-
| Protein kinase A (PKA) ||ART, AKAR|| 2000, 2001 || 3-3 || <ref><pubmed>10700148</pubmed></ref><ref><pubmed>11752448</pubmed></ref>
| プロテインキナーゼA (PKA) ||ART, AKAR|| 2000, 2001 || 3-3 || <ref><pubmed>10700148</pubmed></ref><ref><pubmed>11752448</pubmed></ref>
|- Table 1 A list of genetically encoded FRET probes.
|- Table 1 A list of genetically encoded FRET probes.
| Abl ||Picchu|| 2001 || 3-3 || <ref><pubmed>11752449</pubmed></ref>
| Abl ||Picchu|| 2001 || 3-3 || <ref><pubmed>11752449</pubmed></ref>
72行目: 72行目:
| ERK ||Miu2, Erkus, EKAR|| 2006, 2007, 2008 || 3-1,3-3,3-3 || <ref><pubmed>16418172</pubmed></ref><ref><pubmed> 17261026</pubmed></ref><ref><pubmed> 19033456</pubmed></ref>
| ERK ||Miu2, Erkus, EKAR|| 2006, 2007, 2008 || 3-1,3-3,3-3 || <ref><pubmed>16418172</pubmed></ref><ref><pubmed> 17261026</pubmed></ref><ref><pubmed> 19033456</pubmed></ref>
|-
|-
| Insulin receptor ||Phocus|| 2002 || 3-3 || <ref><pubmed>11875431</pubmed></ref>
| インシュリン受容体 ||Phocus|| 2002 || 3-3 || <ref><pubmed>11875431</pubmed></ref>
|-
|-
| Epidermal Growth factor receptor (EGFR) || ||2001 || 3-3 || <ref><pubmed>11752449</pubmed></ref>
| 上皮成長因子受容体 (EGFR) || ||2001 || 3-3 || <ref><pubmed>11752449</pubmed></ref>
|-
|-
| Ataxia telangiectasia mutated (ATM) || || 2007 || 3-3 || <ref><pubmed>17428747</pubmed></ref>
| Ataxia telangiectasia mutated (ATM) || || 2007 || 3-3 || <ref><pubmed>17428747</pubmed></ref>
|-
|-
| Aurora B kinase || || 2008 || 3-3 || <ref><pubmed>18463638</pubmed></ref>
|オーロラBキナーゼ || || 2008 || 3-3 || <ref><pubmed>18463638</pubmed></ref>
|-
|-
| Cyclin B1-CDK1 || || 2010 || 3-3 || <ref><pubmed>20412769</pubmed></ref>
| Cyclin B1-CDK1 || || 2010 || 3-3 || <ref><pubmed>20412769</pubmed></ref>
98行目: 98行目:
| DAPK1 ||DAPK1(334)-F40|| 2011 || 3-1 || <ref><pubmed>21506563</pubmed></ref>
| DAPK1 ||DAPK1(334)-F40|| 2011 || 3-1 || <ref><pubmed>21506563</pubmed></ref>
|-
|-
| ホスファターゼ || Calcineurin ||CaNAR1|| 2008, 2013 || 3-1 || <ref><pubmed>23602566</pubmed></ref><ref><pubmed> 18493642</pubmed></ref>
| ホスファターゼ || カルシニューリン ||CaNAR1|| 2008, 2013 || 3-1 || <ref><pubmed>23602566</pubmed></ref><ref><pubmed> 18493642</pubmed></ref>
|-
|-
|rowspan="8" | Small GTPase || Ras ||Raichu-Ras, Fras|| 2001, 2006 || 3-2,2 || <ref><pubmed>16429133</pubmed></ref><ref name=ref11429608><pubmed> 11429608</pubmed></ref>
|rowspan="8" | 低分子量GTPアーゼ || Ras ||Raichu-Ras, Fras|| 2001, 2006 || 3-2,2 || <ref><pubmed>16429133</pubmed></ref><ref name=ref11429608><pubmed> 11429608</pubmed></ref>
|-
|-
| Rap ||Raichu-Rap|| 2001 || 3-2 || <ref name=ref11429608></ref>
| Rap ||Raichu-Rap|| 2001 || 3-2 || <ref name=ref11429608></ref>
116行目: 116行目:
| TC10 ||Raichu-TC10|| 2006 || 3-2 || <ref><pubmed>16950130</pubmed></ref>
| TC10 ||Raichu-TC10|| 2006 || 3-2 || <ref><pubmed>16950130</pubmed></ref>
|-
|-
|rowspan="6" | Signal transduction || RCC1(GEF of Ran) ||CFP-RCC1-YFP|| 2008 || 3-1 || <ref><pubmed>18762580</pubmed></ref>
|rowspan="6" | シグナル伝達 || RCC1(GEF of Ran) ||CFP-RCC1-YFP|| 2008 || 3-1 || <ref><pubmed>18762580</pubmed></ref>
|-
|-
| CrkII phosphorylation ||Picchu|| 2001 || 3-1 || <ref><pubmed>11406630</pubmed></ref>
| CrkII phosphorylation ||Picchu|| 2001 || 3-1 || <ref><pubmed>11406630</pubmed></ref>
122行目: 122行目:
| N-WASP ||Stinger|| 2004 || 3-1 || <ref><pubmed>15084285</pubmed></ref><ref><pubmed> 14732696</pubmed></ref>
| N-WASP ||Stinger|| 2004 || 3-1 || <ref><pubmed>15084285</pubmed></ref><ref><pubmed> 14732696</pubmed></ref>
|-
|-
| Adrenergic receptor ||α<sub>2A</sub>AR-cam|| 2003 || 3-1 || <ref name=ref12808462><pubmed>12808462</pubmed></ref>
| アドレナリン受容体 ||α<sub>2A</sub>AR-cam|| 2003 || 3-1 || <ref name=ref12808462><pubmed>12808462</pubmed></ref>
|-
|-
| Parathyroid hormone receptor ||PTHR-cam|| 2003 || 3-1 || <ref name=ref12808462></ref>
| Parathyroid hormone receptor ||PTHR-cam|| 2003 || 3-1 || <ref name=ref12808462></ref>
|-
|-
| Plasma membrane Calcium pump ||BFP-PMCA-GFP|| 2007 || 3-1 || <ref><pubmed>17901055</pubmed></ref>
| 細胞膜カルシウムポンプ ||BFP-PMCA-GFP|| 2007 || 3-1 || <ref><pubmed>17901055</pubmed></ref>
|-
|-
| Acetylation || Histone acetylation ||Histac|| 2004, 2009 || 3-3 || <ref><pubmed>15137760</pubmed></ref><ref><pubmed> 19805290</pubmed></ref>
| アセチル化 || ヒストンアセチル化 ||Histac|| 2004, 2009 || 3-3 || <ref><pubmed>15137760</pubmed></ref><ref><pubmed> 19805290</pubmed></ref>
|-
|-
|rowspan="6" | Lipid || Phosphatidylinositol (3,4,5)-trisphosphate (PIP3) ||Fllip, FLIMPA|| 2003 || 3-4 || <ref><pubmed>14528311</pubmed></ref>
|rowspan="6" | 脂質 || Phosphatidylinositol (3,4,5)-trisphosphate (PIP3) ||Fllip, FLIMPA|| 2003 || 3-4 || <ref><pubmed>14528311</pubmed></ref>
|-
|-
| Phosphatidylinositol (4,5)-bisphosphate (PIP2) ||Pippi-PI(4,5)P<sub>2</sub>|| 2008 || 3-4 || <ref name=ref18685081><pubmed>18685081</pubmed></ref>
| Phosphatidylinositol (4,5)-bisphosphate (PIP2) ||Pippi-PI(4,5)P<sub>2</sub>|| 2008 || 3-4 || <ref name=ref18685081><pubmed>18685081</pubmed></ref>
138行目: 138行目:
| Phosphatidylinositol 4-phosphate (PI4P) ||Pippi-PI(4)P|| 2008 || 3-4 || <ref name=ref18685081></ref>
| Phosphatidylinositol 4-phosphate (PI4P) ||Pippi-PI(4)P|| 2008 || 3-4 || <ref name=ref18685081></ref>
|-
|-
| Phosphatidic acid ||Pii|| 2010 || 3-4 || <ref><pubmed>20826779</pubmed></ref>
| ホスファチジン酸 ||Pii|| 2010 || 3-4 || <ref><pubmed>20826779</pubmed></ref>
|-
|-
| Diacylglycerol (DAG) ||Daglas, DIGDA|| 2006, 2008 || 3-4 || <ref><pubmed>18685081</pubmed></ref><ref><pubmed> 16990811</pubmed></ref>
| ジアシルグリセロール (DAG) ||Daglas, DIGDA|| 2006, 2008 || 3-4 || <ref><pubmed>18685081</pubmed></ref><ref><pubmed> 16990811</pubmed></ref>
|-
|-
|rowspan="6" | Protein interaction || Actin || ||2004, 2008 || 2 || <ref><pubmed>15361876</pubmed></ref><ref><pubmed> 18512154</pubmed></ref>
|rowspan="6" | タンパク質相互作用 || アクチン || ||2004, 2008 || 2 || <ref><pubmed>15361876</pubmed></ref><ref><pubmed> 18512154</pubmed></ref>
|-
|-
| PDK1-Akt interaction || ||2007 || 2 || <ref><pubmed>17407381</pubmed></ref>
| PDK1-Akt interaction || ||2007 || 2 || <ref><pubmed>17407381</pubmed></ref>
154行目: 154行目:
| PTEN-Myosin V interaction || ||2009 || 2 || <ref><pubmed>19767745</pubmed></ref>
| PTEN-Myosin V interaction || ||2009 || 2 || <ref><pubmed>19767745</pubmed></ref>
|-
|-
|rowspan="8" | Protease || Caspase-3 ||EGFP-DEVD-EBFP|| 1998 || 1 || <ref><pubmed>9518501</pubmed></ref>
|rowspan="8" | プロテアーゼ || カスパーゼ-3 ||EGFP-DEVD-EBFP|| 1998 || 1 || <ref><pubmed>9518501</pubmed></ref>
|-
|-
| Caspase-8 ||CFP-c3-YFP-c6-mRFP|| 2002 || 1 || <ref><pubmed>12409609</pubmed></ref>
| カスパーゼ-8 ||CFP-c3-YFP-c6-mRFP|| 2002 || 1 || <ref><pubmed>12409609</pubmed></ref>
|-
|-
| Caspase-9 ||SCAT9|| 2011 || 1 || <ref><pubmed>21637712</pubmed></ref>
| カスパーゼ-9 ||SCAT9|| 2011 || 1 || <ref><pubmed>21637712</pubmed></ref>
|-
|-
| Caspase-7 ||VDEVDc|| 2006 || 1 || <ref><pubmed>17946841</pubmed></ref>
| カスパーゼ-7 ||VDEVDc|| 2006 || 1 || <ref><pubmed>17946841</pubmed></ref>
|-
|-
| Matrix Metalloproteinase (MMP) ||YFP-MSS-CFP<sup>display</sup>, MTI-MMP-FRET biosensor|| 2007, 2008 || 1 || <ref><pubmed>17187878</pubmed></ref><ref><pubmed> 18441011</pubmed></ref>  
| マトリックスメタロプロテアーゼ (MMP) ||YFP-MSS-CFP<sup>display</sup>, MTI-MMP-FRET biosensor|| 2007, 2008 || 1 || <ref><pubmed>17187878</pubmed></ref><ref><pubmed> 18441011</pubmed></ref>  
|-
|-
| Protease activity (Factor Xa) || ||1996 || 1 || <ref><pubmed>8707050</pubmed></ref>
| プロテアーゼ活性 (Factor Xa) || ||1996 || 1 || <ref><pubmed>8707050</pubmed></ref>
|-
|-
| Calpain activity ||pYSCS|| 2000 || 1 || <ref><pubmed>10688895</pubmed></ref>
|カルパイン活性||pYSCS|| 2000 || 1 || <ref><pubmed>10688895</pubmed></ref>
|-
|-
| Presenilin ||GFP-PSI-RFP|| 2009 || 3-1 || <ref><pubmed>19924286</pubmed></ref>
| プレセニリン ||GFP-PSI-RFP|| 2009 || 3-1 || <ref><pubmed>19924286</pubmed></ref>
|-
|-
|rowspan="5" | Other || Strain sensor ||stFRET|| 2008 || 3-1 || <ref><pubmed>18479457</pubmed></ref>
|rowspan="5" | Other || Strain sensor ||stFRET|| 2008 || 3-1 || <ref><pubmed>18479457</pubmed></ref>
|-
|-
| Membrane potential ||VSFP, Mermaid, ArcLight, VSFP-Butterfly|| 2001, 2008, 2012 || 3-1 || <ref><pubmed>11454036</pubmed></ref><ref><pubmed> 18622396</pubmed></ref><ref><pubmed> 22958819</pubmed></ref>
| 膜電位 ||VSFP, Mermaid, ArcLight, VSFP-Butterfly|| 2001, 2008, 2012 || 3-1 || <ref><pubmed>11454036</pubmed></ref><ref><pubmed> 18622396</pubmed></ref><ref><pubmed> 22958819</pubmed></ref>
|-
|-
| Myosin II ||GSldCB|| 1998, 2006 || 3-1 || <ref><pubmed>9845076</pubmed></ref><ref><pubmed> 16939200</pubmed></ref>
| ミオシン II ||GSldCB|| 1998, 2006 || 3-1 || <ref><pubmed>9845076</pubmed></ref><ref><pubmed> 16939200</pubmed></ref>
|-
|-
| HIV Rev protein ||YRGnC-11ad|| 2005 || 3-1 || <ref><pubmed>16013840</pubmed></ref>
| ヒト免疫不全ウイルスRevタンパク質 ||YRGnC-11ad|| 2005 || 3-1 || <ref><pubmed>16013840</pubmed></ref>
|-
|-
|| レドックス ||Redoxfluor, Gaskins|| 2010, 2011 || 3-1 || <ref><pubmed>20498274</pubmed></ref><ref><pubmed> 21606117</pubmed></ref>
|| レドックス ||Redoxfluor, Gaskins|| 2010, 2011 || 3-1 || <ref><pubmed>20498274</pubmed></ref><ref><pubmed> 21606117</pubmed></ref>
「https://bsd.neuroinf.jp/wiki/特別:携帯機器差分/23254」から取得